(-)-Camphene

(-)-Camphene

SCHEMBL6552600

C=C1C2CC[C@@H](C2)C1(C)C

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Camphene SCHEMBL14763794 1.00 CNR2 (0.42) CNR2
Camphene SCHEMBL1869438 1.00 CNR2 (0.42) CNR2
(-)-Camphene SCHEMBL8819262 1.00 CNR2 (0.42) CNR2
(-)-Camphene SCHEMBL6675451 1.00 CNR2 (0.42) CNR2
Camphene SCHEMBL8921 1.00 CNR2 (0.42) CNR2
Camphene SCHEMBL1244388 0.98 CNR2 (0.41) CNR2
Camphene SCHEMBL9803985 0.98 CNR2 (0.41) CNR2
Camphene SCHEMBL31057504 0.98 CNR2 (0.41) CNR2
Camphene SCHEMBL31305341 0.98 CNR2 (0.41) CNR2
Camphene SCHEMBL2370360 0.98 CNR2 (0.41) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114854489-B Chamomile essential oil and preparation method and application thereof 北京市农林科学院 2024-03-22 CN claimed
CN-114854489-A Essential oil of Mao Huaju, preparation method and application thereof 北京市农林科学院 2022-08-05 CN claimed
WO-2025096734-A1 MICROCAPSULES FMC CORPORATION (US) 2025-05-08 WO disclosed
US-12233147-B2 Method for treating keratin material HENKEL AG & CO. KGAA (DE) 2025-02-25 US disclosed
CN-114854489-B Chamomile essential oil and preparation method and application thereof 北京市农林科学院 2024-03-22 CN disclosed
CN-114854489-A Essential oil of Mao Huaju, preparation method and application thereof 北京市农林科学院 2022-08-05 CN disclosed
US-20220211601-A1 METHOD FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2022-07-07 US disclosed
EP-1087835-B1 PROCESS FOR PREPARING A CRYSTAL SUSPENSION SYNGENTA LTD (GB) 2004-12-15 EP disclosed
US-6517853-B1 Dispersing a melt, cooling below melting point and ultra-sonically crystallizing from an oil in water emulsion SYNGENTA LIMITED (GB) 2003-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12233147-B2 Method for treating keratin material KRT18, CCNA1, CCNT1 CNR2 3158/4885
US-20220211601-A1 METHOD FOR TREATING KERATIN MATERIAL KRT18, CCNA1, CCNT1 CNR2 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.